Basal and dynamic proinsulin-insulin relationship to assess beta-cell function during OGTT in metabolic disorders.
The fasting proinsulin-to-insulin ratio is a currently used marker of beta-cell dysfunction. This ratio is calculated at the basal condition, but its behavior in dynamic conditions, i.e., during glucose stimulation, could be more informative. Given the different kinetics of the peptides, a mathematical model was necessary to analyze the oral glucose tolerance test (OGTT) data of insulin, C-peptide, and proinsulin in 55 healthy (NGT), 30 impaired glucose-tolerant (IGT), and 31 type 2 diabetic (T2DM) subjects. The model provided for secretion and disappearance of the peptides and an index of beta-cell function under dynamic conditions. Total proinsulin secretion during the OGTT was not different (P > 0.053) among NGT (0.17 +/- 0.01 mmol/l in 3 h), IGT (0.22 +/- 0.02), and T2DM (0.21 +/- 0.02) subjects. The proinsulin-to-insulin molar ratio measured from basal samples was higher (P < 0.0001) in T2DM (0.39 +/- 0.05) than in NGT (0.14 +/- 0.01) and IGT (0.13 +/- 0.02) subjects, and similar results (P < 0.003) were found by the dynamic index (0.27 +/- 0.04, 0.14 +/- 0.01, 0.15 +/- 0.01 in T2DM, NGT, IGT subjects, respectively). The basal ratio significantly correlated with the dynamic index, and the regression line slope was lower than 1 (0.43 +/- 0.08, 0.61 +/- 0.10, and 0.56 +/- 0.03 in NGT, IGT, and T2DM subjects, respectively, P < 0.0001). Impaired beta-cell function in T2DM could then be indicated by proinsulin-to-insulin indexes at both basal and dynamic phases.
Tura
Andrea
A
Metabolic Unit, Institute of Biomedical Engineering, National Research Council, Padua, Italy.
Pacini
Giovanni
G
Kautzky-Willer
Alexandra
A
Ludvik
Bernhard
B
Prager
Rudolf
R
Thomaseth
Karl
K
D000328:Adult; D000465:Algorithms; D002096:C-Peptide / Q000097:blood; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D006943:Hyperglycemia / Q000097:blood; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D007515:Islets of Langerhans / Q000378:metabolism*; D007700:Kinetics; D008659:Metabolic Diseases / Q000175:diagnosis* / Q000378:metabolism*; D008954:Models, Biological; D015233:Models, Statistical; D010186:Pancreatic Function Tests; D011247:Pregnancy; D011254:Pregnancy in Diabetics; D011384:Proinsulin / Q000097:blood / Q000378:metabolism*; D012039:Regional Blood Flow / Q000502:physiology
D002096:C-Peptide; D007328:Insulin; D011384:Proinsulin